The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
Open accessAbstract
We report that in a cohort of 45,965 adults, who were receiving either the ChAdOx1 or the BNT162b2 SARS-CoV-2 vaccines, in those who had no prior infection with SARS-CoV-2, seroconversion rates and quantitative antibody levels after a single dose were lower in older individuals, especially in those aged >60 years. Two vaccine doses achieved high responses across all ages. Antibody levels increased more slowly and to lower levels with a single dose of ChAdOx1 compared with a single dose of BNT162b2, but waned following a single dose of BNT162b2 in older individuals. In descriptive latent class models, we identified four responder subgroups, including a ‘low responder’ group that more commonly consisted of people aged >75 years, males and individuals with long-term health conditions. Given our findings, we propose that available vaccines should be prioritized for those not previously infected and that second doses should be prioritized for individuals aged >60 years. Further data are needed to better understand the extent to which quantitative antibody responses are associated with vaccine-mediated protection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32661-1 · Cited by 4,616
Self-citationKhoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · Nature Medicine · doi:10.1038/s41591-021-01377-8 · Cited by 3,742
Lopez Bernal, J., Andrews, N., Gower, C., Robertson, C., Stowe, J., Tessier, E., Simmons, R., Cottrell, S., Roberts, R., O’Doherty, M., et al. (2021) · BMJ · doi:10.1136/bmj.n1088 · Cited by 1,389
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
Lumley, S. F., O’Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Warren, F., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034545 · Cited by 940
Self-citationAntibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
Krammer, F., Srivastava, K., Alshammary, H., Amoako, A. A., Awawda, M. H., Beach, K. F., Bermúdez-González, M. C., Bielak, D. A., Carreño, J. M., Chernet, R. L., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2101667 · Cited by 696
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
Ebinger, J. E., Fert-Bober, J., Printsev, I., Wu, M., Sun, N., Prostko, J. C., Frias, E. C., Stewart, J. L., Van Eyk, J. E., Braun, J. G., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01325-6 · Cited by 538
Saadat, S., Rikhtegaran Tehrani, Z., Logue, J., Newman, M., Frieman, M. B., Harris, A. D., & Sajadi, M. M. (2021) · JAMA · doi:10.1001/jama.2021.3341 · Cited by 364
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
Ainsworth, M., Andersson, M., Auckland, K., Baillie, J. K., Barnes, E., Beer, S., Beveridge, A., Bibi, S., Blackwell, L., Borak, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30634-4 · Cited by 351
Self-citation
Cited by
Tregoning, J. S., Flight, K. E., Higham, S. L., Wang, Z., & Pierce, B. F. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00592-1 · Cited by 1,125
Pouwels, K. B., Pritchard, E., Matthews, P. C., Stoesser, N., Eyre, D. W., Vihta, K.-D., House, T., Hay, J., Bell, J. I., Newton, J. N., et al. (2021) · doi:10.1101/2021.08.18.21262237 · Cited by 543
Self-citationEffect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants
Eyre, D. W., Taylor, D., Purver, M., Chapman, D., Fowler, T., Pouwels, K. B., Walker, A. S., & Peto, T. E. A. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2116597 · Cited by 464
Self-citationSerological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
(2021) · doi:10.1038/s41467-021-27410-5 · Cited by 117
Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong
Chen, L.-L., Abdullah, S. M. U., Chan, W.-M., Chan, B. P.-C., Ip, J. D., Chu, A. W.-H., Lu, L., Zhang, X., Zhao, Y., Chuang, V. W.-M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31395-0 · Cited by 72
Metadata
- Authors
- Wei, J., Stoesser, N., Matthews, P. C., Ayoubkhani, D., Studley, R., Bell, I., Bell, J. I., Newton, J. N., Farrar, J., Diamond, I., Rourke, E., Howarth, A., Marsden, B. D., Hoosdally, S., Jones, E. Y., Stuart, D. I., Crook, D. W., Peto, T. E. A., Pouwels, K. B., Eyre, D. W., Walker, A. S., the COVID-19 Infection Survey team, Lambert, A., Thomas, T., Black, R., Felton, A., Crees, M., Jones, J., Lloyd, L., Sutherland, E., Pritchard, E., Vihta, K.-D., Doherty, G., Kavanagh, J., Chau, K. K., Hatch, S. B., Ebner, D., Ferreira, L. M., Christott, T., Dejnirattisai, W., Mongkolsapaya, J., Cameron, S., Tamblin-Hopper, P., Wolna, M., Brown, R., Cornall, R., Screaton, G., Lythgoe, K., Bonsall, D., Golubchik, T., Fryer, H., Cox, S., Paddon, K., James, T., House, T., Robotham, J., Birrell, P., Jordan, H., Sheppard, T., Athey, G., Moody, D., Curry, L., Brereton, P., Jarvis, I., Godsmark, A., Morris, G., Mallick, B., Eeles, P., Hay, J., VanSteenhouse, H., & Lee, J.
- Venue
- Nature Microbiology
- Published
- 2021-07-21
- Volume
- 6
- Issue
- 9
- Pages
- 1140-1149
- ISSN
- 2058-5276 (ISSN-L)
- OpenAlex
- W3179750870
- Cited by
- 331
- References
- 30
- FWCI
- 22.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom. https://app.cochat.ai/papers/10.1038/s41564-021-00947-3
- The paper
- Wei, J., Stoesser, N., Matthews, P. C., Ayoubkhani, D., Studley, R., Bell, I., Bell, J. I., Newton, J. N., Farrar, J., Diamond, I., Rourke, E., Howarth, A., Marsden, B. D., Hoosdally, S., Jones, E. Y., Stuart, D. I., Crook, D. W., Peto, T. E. A., Pouwels, K. B., . . . Lee, J. (2021). Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom. Nature Microbiology. https://doi.org/10.1038/s41564-021-00947-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.